-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/RaBrLyur6uTNS8-_nyysj2
April 01, 2009 - Food and Drug Administration and identified as
effective for treating tobacco dependence in nonpregnant … Food and Drug Administration; USPSTF � U.S. Preventive Services Task Force.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/abdominal-aortic-aneurysm-screening
December 10, 2019 - Seven short-term drug trials (n = 1553) of antibiotics, antihypertensive medications, and mast cell stabilizers … with small AAAs (4-5.4 cm)
Pharmacotherapy vs placebo (entire study population)
7 (1553)
Drug … stabilizer showed no overall effect on AAA growth compared with placebo
Consistency NA (different drug … imprecise
Doxycycline: consistent, imprecise
Other drugs: NA for consistency (1 trial for each drug … ); imprecise
One to 2 trials per drug class with limited harms reporting
Low
Predominantly male
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/by8VJVre6h6BmadrGxaFMM
April 01, 2016 - cardiovascular disease (CVD) events and
the 2007 recommendation on aspirin and nonsteroidal anti-
inflammatory drug … Nonsteroidal anti-
inflammatory drug therapy combined with aspirin use
increases the risk for serious … Food and Drug Administration recently
denied a manufacturer's request to add primary pre-
vention of … Food and Drug Administration. Citizen Petition Denial Re-
sponse From FDA to Bayer Healthcare LLC. … Food and Drug Administration; 2014.
Accessed at www.regulations.gov/#!
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan138/breastfeeding-primary-care-interventions
December 18, 2014 - of women or infants (e.g., institutionalized women, infants with prenatal disease, infants born to drug-using
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan138/breastfeeding-primary-care-interventions-october-2016
December 18, 2014 - of women or infants (e.g., institutionalized women, infants with prenatal disease, infants born to drug-using
-
www.uspreventiveservicestaskforce.org/Home/GetFileByToken/otgsgT2HpLH5gbn4sFN3hw
June 01, 2013 - Children in families with the following are
also at increased risk: strained or bad relationships, drug
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/high-blood-pressure-adults-children-adolescents-screening-2003
April 01, 2003 - sufficiently bothersome to interfere with adherence to the medication regimen—are common, but serious adverse drug … Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/PdBbRgWKPMbHfeQeHkM242
February 01, 2010 - clinical practice, obesity, screening
ABBREVIATIONS
USPSTF—US Preventive Services Task Force
FDA—Food and Drug … Sibutramine, a centrally acting appe-
tite suppressant, has been approved
by the US Food and Drug Administra
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
June 26, 2018 - Eligible treatments included US Food and Drug Administration (FDA)–approved pharmacotherapy (specifically … [95% CI, 0.98-1.05]; I 2 = 0.0%; 13 RCTs [20,485 participants]) for any individual bisphosphonate drug … or race
Fair
KQ4b: Effectiveness of Pharmacotherapy by Subgroup
Women
4 (varies by drug … Consistency unknown (single trial); precise
No evidence of reporting bias
Single trial for each drug … Abbreviations: BMD, bone mineral density; EPC, Evidence-based Practice Center; FDA, US Food and Drug
-
www.uspreventiveservicestaskforce.org/uspstf/document/comparative-effectiveness-of-antiviral-treatment-for-hepatitis-c-virus-infection-in-adults-a-systematic-review/hepatitis-c-screening-2013
November 15, 2012 - Food and Drug Administration. … Approval of Victrelis (boceprevir) a direct acting antiviral drug (DAA) to treat hepatitis C virus (HCV … Food and Drug Administration. … Food and Drug Administration for boceprevir in antiviral-naive patients with cirrhosis at baseline. … Food and Drug Administration for telaprevir.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wezro6zTSfAWxCrneF-nxB
May 01, 2005 - Food and Drug Administration (FDA) approved tests, PACE® 2 and the Hybrid
Capture II®, can detect C. … 31, 48
partner with symptoms of STD,31 inconsistent or no use of barrier contraception,14, 28, 31 drug … The presence of risk factors, such as a history of STD, drug use, and age less
than 20 years, increased … Drug Alcohol Depend
2003;70(1):93-9.
9. Farley TA, Cohen DA, Elkins W. … ED, emergency department;
GC, gonorrhea;
IVDU, intravenous drug user;
MSM, men who have sex with men;
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - bleeding with low-dose aspirin use include concurrent anticoagulation or nonsteroidal anti-inflammatory drug … anticoagulation or NSAID use, and uncontrolled hypertension. 4 , 5 Nonsteroidal anti-inflammatory drug … Food and Drug Administration recently denied a manufacturer’s request to add primary prevention of MI … Food and Drug Administration. Citizen Petition Denial Response From FDA to Bayer Healthcare LLC. … Food and Drug Administration; 2014. Accessed at www.regulations.gov/#!
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/hiv-prep-prevention-discussion-guide-spanish.pdf
August 22, 2023 - varias formas de tomar la PrEP aprobada por la Administración de Alimentos y Medicamentos (Food and Drug
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/brca-related-cancer-risk-assessment-genetic-counseling-testing
January 18, 2024 - Food and Drug Administration, KQ=Key Question.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
November 13, 2016 - The US Food and Drug Administration (FDA) review of atorvastatin reported 29 vs 37 cardiovascular mortality … N Engl J Med . 2008;359(21):2195-2207. doi:10.1056/NEJMoa0807646
Center for Drug Evaluation and Research … US Food and Drug Administration website. … What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug … Placebo (n = 6344)
HYRIM
Anderssen et al, 28
2005
Fair
Men age 40-74 y
Receiving drug
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/BhnZRA--TRpXdg9_tYmZ_M
April 05, 2016 - Few trials reported harms for
any individual drug class. … the treatment questions, the search included treatment ef-
ficacy literature for the following COPD drug … Twenty studies of 14 distinct trials were identified for the 3 in-
cluded drug classes and 1 combination … Unknown: single
subanalysis
identified for
most drug classes
and outcomes
Most subanalyses limited by … and
adverse events too limited
to make conclusions
Unknown: single
subanalysis
identified for
most drug
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-06/understanding-how-USPSTF-works_TF101_Updated-2025.pdf
January 01, 2025 - Food and Drug Administration (FDA)
Public Engagement with the USPSTF
• The Task Force is committed
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-01/understanding-how-uspstf-works-tf101-2025.pdf
January 01, 2025 - Food and Drug Administration (FDA)
Public Engagement with the USPSTF
• The Task Force is committed
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2025-06/understanding-how-uspstf-works-tf101-updated_2025.pdf
January 01, 2025 - Food and Drug Administration (FDA)
Public Engagement with the USPSTF
• The Task Force is committed
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-screening-1996
January 01, 1996 - University Group Diabetes Program study) found no effect of improved glucose control with insulin or drug … chlorpropamide, glibenclamide, metformin, or insulin. 77 Three-year results indicated that patients receiving drug … control in the intervention groups, 76 but the interpretation of these findings has been criticized. 83 Drug … reducing glucose levels compliance of asymptomatic persons with lifestyle advice possible risks of drug … ongoing UKPDS trial demonstrates important clinical benefits from more intensive interventions (i.e., drug